/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Jennifer Athanacio

Pfizer (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

36

Papers

828

Citations

11

h-index

11

i10-index

Jennifer Athanacio is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research & Biosimilars and Bioanalytical Methods. The author has an h-index of 11, co-authored 31 publications.

Research Topics

Monoclonal and Polyclonal Antibodies Research CAR-T cell therapy research Biosimilars and Bioanalytical Methods Regulation of Appetite and Obesity Neuropeptides and Animal Physiology

Papers by this author

works

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight

2009 · International Journal of Obesity · 110 citations

https://doi.org/10.1038/ijo.2009.238

Christine M. Mack Carlos José Soares Julie Wilson Jennifer Athanacio

Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide

2011 · Diabetes Obesity and Metabolism · 50 citations

https://doi.org/10.1111/j.1463-1326.2011.01465.x

Christine M. Mack Porsha Smith Jennifer Athanacio Kui Xu

Research topics

topics

Monoclonal and Polyclonal Antibodies Research

CAR-T cell therapy research

Biosimilars and Bioanalytical Methods

Regulation of Appetite and Obesity

Neuropeptides and Animal Physiology

Chat about Author

Papers

Chat

Click to start Chat